Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (221-230 of 435) with videos related to

Pageof 44
Sort By:
Arthritis Research & Therapy|June 9, 2018
Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 studyIain B McInnes, Philip J Mease, Georg Schett, et al.
Expert Review of Molecular Diagnostics|October 28, 2022
Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritisJeffrey R Curtis, Vibeke Strand, Steven Golombek, et al.
Arthritis Care & Research|November 23, 2020
Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long-Term Results of Two Phase III Randomized Controlled TrialsTore K Kvien, Philip G Conaghan, Laure Gossec, et al.
Expert Review of Molecular Diagnostics|December 23, 2021
Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritisVibeke Strand, Stanley B Cohen, Jeffrey R Curtis, et al.
BMC Rheumatology|September 20, 2021
Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week resultsAtul A Deodhar, Philip J Mease, Proton Rahman, et al.
The Journal of Rheumatology|March 16, 2021
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual MeetingLourdes M Perez-Chada, Alison Kohn, Alice B Gottlieb, et al.
The Journal of Rheumatology|February 3, 2011
A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritisMark C Genovese, Stanley B Cohen, David Wofsy, et al.
Annals of the Rheumatic Diseases|March 19, 2011
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trialVibeke Strand, Josef S Smolen, Ronald F van Vollenhoven, et al.
Arthritis and Rheumatism|April 16, 2002
How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussionDésirée van der Heijde, Lee Simon, Josef Smolen, et al.
The Journal of Rheumatology|September 10, 2009
Measuring worker productivity: frameworks and measuresDorcas Beaton, Claire Bombardier, Reuben Escorpizo, et al.
Pageof 44

Showing results (221-230 of 435) with videos related to

Sort By:
Pageof 44
Arthritis Research & Therapy|June 9, 2018
Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 studyIain B McInnes, Philip J Mease, Georg Schett, et al.
Expert Review of Molecular Diagnostics|October 28, 2022
Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritisJeffrey R Curtis, Vibeke Strand, Steven Golombek, et al.
Arthritis Care & Research|November 23, 2020
Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long-Term Results of Two Phase III Randomized Controlled TrialsTore K Kvien, Philip G Conaghan, Laure Gossec, et al.
Expert Review of Molecular Diagnostics|December 23, 2021
Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritisVibeke Strand, Stanley B Cohen, Jeffrey R Curtis, et al.
BMC Rheumatology|September 20, 2021
Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week resultsAtul A Deodhar, Philip J Mease, Proton Rahman, et al.
The Journal of Rheumatology|March 16, 2021
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual MeetingLourdes M Perez-Chada, Alison Kohn, Alice B Gottlieb, et al.
The Journal of Rheumatology|February 3, 2011
A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritisMark C Genovese, Stanley B Cohen, David Wofsy, et al.
Annals of the Rheumatic Diseases|March 19, 2011
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trialVibeke Strand, Josef S Smolen, Ronald F van Vollenhoven, et al.
Arthritis and Rheumatism|April 16, 2002
How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussionDésirée van der Heijde, Lee Simon, Josef Smolen, et al.
The Journal of Rheumatology|September 10, 2009
Measuring worker productivity: frameworks and measuresDorcas Beaton, Claire Bombardier, Reuben Escorpizo, et al.
Pageof 44